194 related articles for article (PubMed ID: 19941841)
1. Cholinesterase inhibitors and memory.
Pepeu G; Giovannini MG
Chem Biol Interact; 2010 Sep; 187(1-3):403-8. PubMed ID: 19941841
[TBL] [Abstract][Full Text] [Related]
2. Effect of cholinesterase inhibitors on attention.
Pepeu G; Giovannini MG; Bracco L
Chem Biol Interact; 2013 Mar; 203(1):361-4. PubMed ID: 23047023
[TBL] [Abstract][Full Text] [Related]
3. Combined blockade of cholinergic receptors shifts the brain from stimulus encoding to memory consolidation.
Rasch BH; Born J; Gais S
J Cogn Neurosci; 2006 May; 18(5):793-802. PubMed ID: 16768378
[TBL] [Abstract][Full Text] [Related]
4. Changes in acetylcholine extracellular levels during cognitive processes.
Pepeu G; Giovannini MG
Learn Mem; 2004; 11(1):21-7. PubMed ID: 14747513
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of cognitive rehabilitation in patients with mild cognitive impairment treated with cholinesterase inhibitors.
Rozzini L; Costardi D; Chilovi BV; Franzoni S; Trabucchi M; Padovani A
Int J Geriatr Psychiatry; 2007 Apr; 22(4):356-60. PubMed ID: 17117398
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of hippocampal function in mild cognitive impairment: targeting the cholinergic hypothesis.
Grön G; Brandenburg I; Wunderlich AP; Riepe MW
Neurobiol Aging; 2006 Jan; 27(1):78-87. PubMed ID: 16298243
[TBL] [Abstract][Full Text] [Related]
7. The cholinergic system and spatial learning.
Deiana S; Platt B; Riedel G
Behav Brain Res; 2011 Aug; 221(2):389-411. PubMed ID: 21108971
[TBL] [Abstract][Full Text] [Related]
8. Cholinesterase inhibitors and beyond.
Pepeu G; Giovannini MG
Curr Alzheimer Res; 2009 Apr; 6(2):86-96. PubMed ID: 19355843
[TBL] [Abstract][Full Text] [Related]
9. Sex influences on cholinesterase inhibitor treatment in elderly individuals with Alzheimer's disease.
Haywood WM; Mukaetova-Ladinska EB
Am J Geriatr Pharmacother; 2006 Sep; 4(3):273-86. PubMed ID: 17062329
[TBL] [Abstract][Full Text] [Related]
10. Domain-specific improvement of cognition on memantine in patients with Alzheimer's disease treated with rivastigmine.
Riepe MW; Adler G; Ibach B; Weinkauf B; Tracik F; Gunay I
Dement Geriatr Cogn Disord; 2007; 23(5):301-6. PubMed ID: 17356273
[TBL] [Abstract][Full Text] [Related]
11. The role of the AT4 and cholinergic systems in the Nucleus Basalis Magnocellularis (NBM): effects on spatial memory.
Wilson WL; Munn C; Ross RC; Harding JW; Wright JW
Brain Res; 2009 May; 1272():25-31. PubMed ID: 19328191
[TBL] [Abstract][Full Text] [Related]
12. Intraseptal muscarinic ligands and galanin: influence on hippocampal acetylcholine and cognition.
Elvander E; Schött PA; Sandin J; Bjelke B; Kehr J; Yoshitake T; Ogren SO
Neuroscience; 2004; 126(3):541-57. PubMed ID: 15183504
[TBL] [Abstract][Full Text] [Related]
13. Cholinergic challenge in Alzheimer patients and mild cognitive impairment differentially affects hippocampal activation--a pharmacological fMRI study.
Goekoop R; Scheltens P; Barkhof F; Rombouts SA
Brain; 2006 Jan; 129(Pt 1):141-57. PubMed ID: 16251213
[TBL] [Abstract][Full Text] [Related]
14. Beneficial effect of cholinesterase inhibitor medications on recognition memory performance in mild to moderate Alzheimer's disease: preliminary findings.
Crowell TA; Paramadevan J; Abdullah L; Mullan M
J Geriatr Psychiatry Neurol; 2006 Mar; 19(1):13-5. PubMed ID: 16449754
[TBL] [Abstract][Full Text] [Related]
15. Acetylcholine and attention.
Klinkenberg I; Sambeth A; Blokland A
Behav Brain Res; 2011 Aug; 221(2):430-42. PubMed ID: 21108972
[TBL] [Abstract][Full Text] [Related]
16. Have cholinergic therapies reached their clinical boundary in Alzheimer's disease?
Jones RW
Int J Geriatr Psychiatry; 2003 Sep; 18(Suppl 1):S7-S13. PubMed ID: 12973745
[TBL] [Abstract][Full Text] [Related]
17. Responsiveness to cholinesterase inhibitors in Alzheimer's disease: a possible role for the 192 Q/R polymorphism of the PON-1 gene.
Pola R; Flex A; Ciaburri M; Rovella E; Valiani A; Reali G; Silveri MC; Bernabei R
Neurosci Lett; 2005 Jul; 382(3):338-41. PubMed ID: 15925115
[TBL] [Abstract][Full Text] [Related]
18. The effects of long-term treatment with metrifonate, a cholinesterase inhibitor, on cholinergic activity, amyloid pathology, and cognitive function in APP and PS1 doubly transgenic mice.
Liu L; Ikonen S; Heikkinen T; Tapiola T; van Groen T; Tanila H
Exp Neurol; 2002 Feb; 173(2):196-204. PubMed ID: 11822883
[TBL] [Abstract][Full Text] [Related]
19. Chronic brain cytochrome oxidase inhibition selectively alters hippocampal cholinergic innervation and impairs memory: prevention by ladostigil.
Luques L; Shoham S; Weinstock M
Exp Neurol; 2007 Aug; 206(2):209-19. PubMed ID: 17580085
[TBL] [Abstract][Full Text] [Related]
20. Physostigmine reverses cognitive dysfunction caused by moderate hypoxia in adult mice.
Bekker A; Haile M; Gingrich K; Wenning L; Gorny A; Quartermain D; Blanck T
Anesth Analg; 2007 Sep; 105(3):739-43. PubMed ID: 17717233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
